{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T16:30:10Z","timestamp":1788366610227,"version":"build-2803163510"},"reference-count":48,"publisher":"Elsevier BV","issue":"3","content-domain":{"domain":["jdsjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Dermatological Science"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1016\/j.jdermsci.2014.02.002","type":"journal-article","created":{"date-parts":[[2014,2,17]],"date-time":"2014-02-17T06:45:20Z","timestamp":1392619520000},"page":"251-259","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["Effects of the immunosuppressant rapamycin on the expression of human \u03b12(I) collagen and matrix metalloproteinase 1 genes in scleroderma dermal fibroblasts"],"prefix":"10.1016","volume":"74","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5706-9883","authenticated-orcid":false,"given":"Zenshiro","family":"Tamaki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihide","family":"Asano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahide","family":"Kubo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hironobu","family":"Ihn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yayoi","family":"Tada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Sugaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takafumi","family":"Kadono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinichi","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jdermsci.2014.02.002_bib0005","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1136\/ard.2004.027094","article-title":"Early T cell activation in the skin from patients with systemic sclerosis","volume":"64","author":"Kalogerou","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jdermsci.2014.02.002_bib0010","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1002\/art.20274","article-title":"Altered blood B lymphocyte homeostasis in systemic sclerosis: expanded naive B cells and diminished but activated memory B cells","volume":"50","author":"Sato","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jdermsci.2014.02.002_bib0015","first-page":"202","article-title":"Scleroderma (systemic sclerosis): classification, subsets and pathogenesis","volume":"15","author":"LeRoy","year":"1988","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jdermsci.2014.02.002_bib0020","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1002\/art.1780270607","article-title":"Lymphocytes in the skin of patients with progressive systemic sclerosis. Quantification, subtyping, and clinical correlations","volume":"27","author":"Roumm","year":"1984","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jdermsci.2014.02.002_bib0025","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/j.1365-2249.1990.tb08094.x","article-title":"phenotypic analysis of T lymphocytes cloned from the skin of patients with systemic sclerosis","volume":"79","author":"Ferrarini","year":"1990","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jdermsci.2014.02.002_bib0030","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1002\/art.1780340913","article-title":"Expression and function of surface antigens on scleroderma fibroblasts","volume":"34","author":"Abraham","year":"1991","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jdermsci.2014.02.002_bib0035","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/j.1600-0625.1992.tb00187.x","article-title":"Altered regulation of collagen metabolism in scleroderma fibroblasts grown within three-dimensional collagen gels","volume":"1","author":"Mauch","year":"1992","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.jdermsci.2014.02.002_bib0040","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1097\/00002281-199511000-00013","article-title":"Immunologic aspects of scleroderma","volume":"7","author":"White","year":"1995","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.jdermsci.2014.02.002_bib0045","doi-asserted-by":"crossref","first-page":"2655","DOI":"10.1056\/NEJMoa055120","article-title":"Cyclophosphamide versus placebo in scleroderma lung disease","volume":"354","author":"Tashkin","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jdermsci.2014.02.002_bib0050","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1002\/art.1780360113","article-title":"Cyclosporine in systemic sclerosis. Results of a forty-eight-week open safety study in ten patients","volume":"36","author":"Clements","year":"1993","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jdermsci.2014.02.002_bib0055","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1093\/rheumatology\/39.8.865","article-title":"Cyclosporin and tacrolimus: their use in a routine clinical setting for scleroderma","volume":"39","author":"Morton","year":"2000","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jdermsci.2014.02.002_bib0060","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1093\/rheumatology\/35.4.364","article-title":"Comparison of methotrexate with placebo in the treatment of systemic sclerosis: a 24 week randomized double-blind trial, followed by a 24 week observational trial","volume":"35","author":"van den Hoogen","year":"1996","journal-title":"Br J Rheumatol"},{"key":"10.1016\/j.jdermsci.2014.02.002_bib0065","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1002\/1529-0131(200106)44:6<1351::AID-ART227>3.0.CO;2-I","article-title":"A randomized, controlled trial of methotrexate versus placebo in early diffuse scleroderma","volume":"44","author":"Pope","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jdermsci.2014.02.002_bib0070","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1093\/rheumatology\/kel244","article-title":"Mycophenolate mofetil in diffuse cutaneous systemic sclerosis \u2013 a retrospective analysis","volume":"46","author":"Nihtyanova","year":"2007","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jdermsci.2014.02.002_bib0075","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1136\/ard.2010.142000","article-title":"Long-term experience of mycophenolate mofetil for treatment of diffuse cutaneous systemic sclerosis","volume":"70","author":"Le","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jdermsci.2014.02.002_bib0080","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1101\/gad.1212704","article-title":"Upstream and downstream of mTOR","volume":"18","author":"Hay","year":"2004","journal-title":"Genes Dev"},{"key":"10.1016\/j.jdermsci.2014.02.002_bib0085","first-page":"283","article-title":"mTOR: a mediator of intracellular homeostasis","volume":"279","author":"Jaeschke","year":"2004","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.1016\/j.jdermsci.2014.02.002_bib0090","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1038\/369756a0","article-title":"A mammalian protein targeted by G1-arresting rapamycin\u2013receptor complex","volume":"369","author":"Brown","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.jdermsci.2014.02.002_bib0095","doi-asserted-by":"crossref","first-page":"251","DOI":"10.4049\/jimmunol.144.1.251","article-title":"Distinct mechanisms of suppression of murine T cell activation by the related macrolides FK-506 and rapamycin","volume":"144","author":"Dumont","year":"1990","journal-title":"J Immunol"},{"key":"10.1016\/j.jdermsci.2014.02.002_bib0100","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1016\/j.transproceed.2005.02.101","article-title":"Successful conversion to rapamycin for calcineurin inhibitor-related neurotoxicity following liver transplantation","volume":"37","author":"Forgacs","year":"2005","journal-title":"Transplant Proc"},{"key":"10.1016\/j.jdermsci.2014.02.002_bib0105","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1016\/j.transproceed.2008.10.019","article-title":"Fifteen years of clinical studies and clinical practice in renal transplantation: reviewing outcomes with de novo use of sirolimus in combination with cyclosporine","volume":"40","author":"Kahan","year":"2008","journal-title":"Transplant Proc"},{"key":"10.1016\/j.jdermsci.2014.02.002_bib0110","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1097\/01.tp.0000219703.39149.85","article-title":"Target of rapamycin inhibitors (sirolimus and everolimus) for primary immunosuppression of kidney transplant recipients: a systematic review and meta-analysis of randomized trials","volume":"81","author":"Webster","year":"2006","journal-title":"Transplantation"},{"key":"10.1016\/j.jdermsci.2014.02.002_bib0115","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/j.jhep.2006.07.030","article-title":"Low-dose oral rapamycin treatment reduces fibrogenesis, improves liver function, and prolongs survival in rats with established liver cirrhosis","volume":"45","author":"Neef","year":"2006","journal-title":"J Hepatol"},{"issue":"6","key":"10.1016\/j.jdermsci.2014.02.002_bib0120","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1183\/09031936.02.00281602","article-title":"The rapamycin analogue SDZ RAD attenuates bleomycin-induced pulmonary fibrosis in rats","volume":"19","author":"Simler","year":"2002","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jdermsci.2014.02.002_bib0125","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1002\/art.20934","article-title":"Differential effects of the immunosuppressant FK-506 on human \u03b12(I) collagen gene expression and transforming growth factor-\u03b2 signaling in normal and scleroderma fibroblasts","volume":"52","author":"Asano","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jdermsci.2014.02.002_bib0130","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.1002\/art.27498","article-title":"Treatment with rapamycin prevents fibrosis in tight-skin and bleomycin-induced mouse models of systemic sclerosis","volume":"62","author":"Yoshizaki","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jdermsci.2014.02.002_bib0135","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/S0002-9440(10)63215-4","article-title":"Increased expression levels of integrin \u03b1V\u03b25 on scleroderma fibroblasts","volume":"164","author":"Asano","year":"2004","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jdermsci.2014.02.002_bib0140","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1172\/JCI16269","article-title":"Impaired Smad7-Smurf-mediated negative regulation of TGF-\u03b2 signaling in scleroderma fibroblasts","volume":"113","author":"Asano","year":"2004","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jdermsci.2014.02.002_bib0145","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1042\/bj3230603","article-title":"Modified proenzymes as artificial substrates for proteolytic enzymes: colorimetric assay of bacterial collagenase and matrix metalloproteinase activity using modified pro-urokinase","volume":"323","author":"Verheijen","year":"1997","journal-title":"Biochem J"},{"key":"10.1016\/j.jdermsci.2014.02.002_bib0150","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1016\/S0002-9440(10)62362-0","article-title":"Constitutive thrombospondin-1 overexpression contributes to autocrine transforming growth factor-\u03b2 signaling in cultured scleroderma fibroblasts","volume":"166","author":"Mimura","year":"2005","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jdermsci.2014.02.002_bib0155","doi-asserted-by":"crossref","first-page":"33045","DOI":"10.1074\/jbc.M606366200","article-title":"Modulation of collagen and MMP-1 gene expression in fibroblasts by the immunosuppressive drug rapamycin. A direct role as an antifibrotic agent?","volume":"281","author":"Poulalhon","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jdermsci.2014.02.002_bib0160","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1677\/joe.0.1570361","article-title":"Post-transcriptional gene regulatory mechanisms in eukaryotes: an overview","volume":"157","author":"Day","year":"1998","journal-title":"J Endocrinol"},{"key":"10.1016\/j.jdermsci.2014.02.002_bib0165","doi-asserted-by":"crossref","first-page":"13864","DOI":"10.1074\/jbc.272.21.13864","article-title":"Regulation of type I collagen mRNA by amino acid deprivation in human lung fibroblasts","volume":"272","author":"Krupsky","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jdermsci.2014.02.002_bib0170","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1016\/S0006-291X(87)80209-7","article-title":"PGE2 causes a coordinate decrease in the steady state levels of fibronectin and types I and III procollagen mRNAs in normal human dermal fibroblasts","volume":"147","author":"Varga","year":"1987","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jdermsci.2014.02.002_bib0175","doi-asserted-by":"crossref","first-page":"5575","DOI":"10.1128\/MCB.22.15.5575-5584.2002","article-title":"The immunosuppressant rapamycin mimics a starvation-like signal distinct from amino acid and glucose deprivation","volume":"22","author":"Peng","year":"2002","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.jdermsci.2014.02.002_bib0180","doi-asserted-by":"crossref","first-page":"17595","DOI":"10.1074\/jbc.M109.001735","article-title":"Enhanced endothelial cell senescence by lithium-induced matrix metalloproteinase-1 expression","volume":"284","author":"Struewing","year":"2009","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jdermsci.2014.02.002_bib0185","doi-asserted-by":"crossref","first-page":"4818","DOI":"10.1093\/nar\/22.22.4818","article-title":"Regulation of collagenase gene expression by IL-1\u03b2 requires transcriptional and post-transcriptional mechanisms","volume":"22","author":"Vincenti","year":"1994","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.jdermsci.2014.02.002_bib0190","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1615\/CritRevEukarGeneExpr.v6.i4.40","article-title":"Regulating expression of the gene for matrix metalloproteinase-1 (collagenase): mechanisms that control enzyme activity, transcription, and mRNA stability","volume":"6","author":"Vincenti","year":"1996","journal-title":"Crit Rev Eukaryot Gene Expr"},{"key":"10.1016\/j.jdermsci.2014.02.002_bib0195","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1096\/fasebj.13.8.781","article-title":"Regulation of matrix metalloproteinase expression in tumor invasion","volume":"13","author":"Westermarck","year":"1999","journal-title":"FASEB J"},{"key":"10.1016\/j.jdermsci.2014.02.002_bib0200","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1007\/s004030050241","article-title":"Gene expression of types I and III collagen, decorin, matrix metalloproteinases and tissue inhibitors of metalloproteinases in skin fibroblasts from patients with systemic sclerosis","volume":"289","author":"Kuroda","year":"1997","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.jdermsci.2014.02.002_bib0205","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/1523-1747.ep12394936","article-title":"Decreased collagenase expression in cultured systemic sclerosis fibroblasts","volume":"103","author":"Takeda","year":"1994","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jdermsci.2014.02.002_bib0210","doi-asserted-by":"crossref","first-page":"3821","DOI":"10.1002\/art.24986","article-title":"Rapamycin versus methotrexate in early diffuse systemic sclerosis results from a randomized, single-blind pilot study","volume":"60","author":"Su","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jdermsci.2014.02.002_bib0215","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1097\/01.bor.0000137894.63091.1a","article-title":"Recent advances in fibroblast signaling and biology in scleroderma","volume":"16","author":"Pannu","year":"2004","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.jdermsci.2014.02.002_bib0220","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1158\/0008-5472.CAN-08-2146","article-title":"Distinct roles for mammalian target of rapamycin complexes in the fibroblast response to transforming growth factor-\u03b2","volume":"69","author":"Rahimi","year":"2009","journal-title":"Cancer Res"},{"key":"10.1016\/j.jdermsci.2014.02.002_bib0225","doi-asserted-by":"crossref","first-page":"7424","DOI":"10.1167\/iovs.13-12674","article-title":"Rapamycin inhibits the production of myofibroblasts and reduces corneal scarring after photorefractive keratectomy","volume":"54","author":"Milani","year":"2013","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jdermsci.2014.02.002_bib0230","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1002\/1529-0131(199809)41:9<1613::AID-ART11>3.0.CO;2-O","article-title":"Case\u2013control study of corticosteroids and other drugs that either precipitate or protect from the development of scleroderma renal crisis","volume":"41","author":"Steen","year":"1998","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jdermsci.2014.02.002_bib0235","doi-asserted-by":"crossref","first-page":"R30","DOI":"10.1186\/ar2634","article-title":"High frequency of corticosteroid and immunosuppressive therapy in patients with systemic sclerosis despite limited evidence for efficacy","volume":"11","author":"Hunzelmann","year":"2009","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.jdermsci.2014.02.002_bib0240","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1034\/j.1399-0012.2000.140201.x","article-title":"Therapeutic drug monitoring of sirolimus: correlations with efficacy and toxicity","volume":"14","author":"Kahan","year":"2000","journal-title":"Clin Transplant"}],"container-title":["Journal of Dermatological Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092318111400036X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092318111400036X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,7,10]],"date-time":"2023-07-10T14:06:16Z","timestamp":1688997976000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S092318111400036X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6]]},"references-count":48,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,6]]}},"alternative-id":["S092318111400036X"],"URL":"https:\/\/doi.org\/10.1016\/j.jdermsci.2014.02.002","relation":{},"ISSN":["0923-1811"],"issn-type":[{"value":"0923-1811","type":"print"}],"subject":[],"published":{"date-parts":[[2014,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of the immunosuppressant rapamycin on the expression of human \u03b12(I) collagen and matrix metalloproteinase 1 genes in scleroderma dermal fibroblasts","name":"articletitle","label":"Article Title"},{"value":"Journal of Dermatological Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdermsci.2014.02.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Japanese Society for Investigative Dermatology. Published by Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}